Lewis Y (Tumor Marker) (A70-C/C8), 0.2mg/mL Antibody | BNUB1411-100
- SKU:
- 37-BNUB1411-100
- Availability:
- IN STOCK
- Size:
- 100 uL
Description
Lewis Y (Tumor Marker) (A70-C/C8), 0.2mg/mL Antibody | BNUB1411-100| Gentaur Distribution US, UK & Europe
Summary.: This antibody recognizes a carbohydrate epitope common to the tumor-associated Lewis Y and Lewis b antigens (Fucalpha1-2Galbeta1-4/3GlcNAcbeta). Its specificity was established without doubt with a panel of 86 synthetic mono- and oligosaccharidic structures. Lewis Y is expressed in large bowel tumors and colorectal carcinomas. It may be useful in the classification of human renal and bladder tumors. The Lewis Y antigen has been evaluated as a clinical marker for the diagnosis and prognosis of cholangiocarcinoma, hepatocellular carcinoma and breast cancer.This antibody is available purified with BSA/azide at 200 ug/mL, or BSA/azide-free at 1 mg/mL..
Conjugate: Purified, with BSA.
Storage Buffer: PBS, 0.05% BSA, 0.05% azide.
Storage Temperature: 2°C to 8°C.
Application: .
Stability: Stable at room temperature or 37°C (98°F) for 7 days.
Related Products
Lewis Y (Tumor Marker) (A70-A/A9), 0.2mg/mL Antibody | BNUB1412-100
Lewis Y (Tumor Marker) (A70-C/C8), 1mg/mL Antibody | BNUM1411-50
Lewis Y (Tumor Marker) (LWY/1463), 0.2mg/mL Antibody | BNUB1463-100
Lewis Y (Tumor Marker) (A70-A/A9), 1mg/mL Antibody | BNUM1412-50
Lewis Y (Tumor Marker) (A70-A/A9), CF568 conjugate, 0.1mg/mL Antibody | BNC681412-100
Lewis Y (Tumor Marker) (A70-A/A9), CF405S conjugate, 0.1mg/mL Antibody | BNC041412-100
Lewis Y (Tumor Marker) (A70-A/A9), CF647 conjugate, 0.1mg/mL Antibody | BNC471412-100
Lewis Y (Tumor Marker) (A70-A/A9), CF488A conjugate, 0.1mg/mL Antibody | BNC881412-100
